News

Statistically significant improvements observed across clinical endpoints; final cohort results expected in Q2 2025 ...
Complete resolution of lung metastasis confirmed at 4 month follow-up in hormone receptor positive (HR+) breast ...
NurExone's ExoTherapy platform enables precise, minimally-invasive delivery of therapies to injured tissues using exosomes as an advanced delivery system. With a growing body of preclinical data and ...
Detailed price information for Briacell Therapeutics Corp WT (BCTXW-Q) from The Globe and Mail including charting and trades.
Knightscope, Inc. (NASDAQ: KSCP), a leader in developing autonomous security robots and artificial intelligence technologies, ...
Oral presentation at ASCO to highlight topline Phase 2 data of elraglusib in combination with gemcitabine/nab-paclitaxel (GnP ...
SEATTLE, WA / ACCESS Newswire / April 22, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology ...
India’s startup landscape is dominated by ventures catering to consumer convenience which are useful, but insufficient for ...
Dr Annie Black, Lancome's international scientific director, talks to Lounge about how pollution is affecting Indian skin and ...
SEATTLE, WA / ACCESS Newswire / April 21, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology ...
Emerging biotech leader AKESF develops Ivonescimab & Cadonilimab; while offering growth potential with US partnerships, ...
Four healthcare dividend stocks with significant upside potential and safe dividends look like outstanding investing ideas ...